中国P站

Recent advancements in stationary phases for high-performance liquid chromatography are revolutionizing analytical separations. The review highlights diverse materials and their applications in enhancing efficiency and selectivity. Innovations in sub-2 µm particles, core-shell structures, and novel bonding chemistries demonstrate a clear direction towards more powerful and versatile chromatographic separations [1].

High-performance liquid chromatography techniques are crucial for pharmaceutical analysis. This review covers method development, validation strategies, and applications in drug discovery, quality control, and impurity profiling. It emphasizes HPLC's critical role in ensuring drug safety and efficacy throughout the pharmaceutical industry, underscoring its indispensable contribution to public health [2].

Miniaturized HPLC systems, including micro- and nano-HPLC, show significant progress. This article focuses on their application in clinical diagnostics and pharmaceutical research. It highlights benefits like reduced sample consumption, enhanced sensitivity, and faster analysis times, demonstrating their potential for complex sample analysis in various scientific fields [3].

The evolution of HPLC-mass spectrometry (MS) techniques, particularly for natural product analysis, is remarkable. This paper details innovations in interface design, ionization methods, and data processing. These improvements enable more precise identification and quantification of complex mixtures, which is crucial for drug discovery and quality control initiatives [4].

Latest developments in chiral stationary phases are crucial for enantioselective separations in HPLC. This review discusses new materials and modifications for improved resolution and efficiency. It underscores the importance of chiral chromatography in pharmaceutical development and synthetic chemistry for isolating and analyzing enantiomers effectively [5].

Advancements in green HPLC methodologies aim to reduce environmental impact in pharmaceutical analysis. This paper covers innovations in solvent reduction, use of eco-friendly mobile phases, and alternative separation modes. It demonstrates efforts to align chromatographic practices with sustainable chemistry principles without compromising analytical performance [6].

Ultra-high performance liquid chromatography (UHPLC) is rapidly advancing in metabolomics. This article illustrates how UHPLC’s superior resolution and speed, combined with advanced detection methods, push the boundaries of metabolite profiling. It offers deeper insights into biological systems and disease mechanisms, fostering significant progress in biomedical research [7].

The integration of chemometric methods with HPLC-DAD and HPLC-MS platforms is enhancing complex phytochemical analysis. This review demonstrates how statistical and multivariate analysis techniques improve the interpretation of chromatographic data. This leads to better compound identification, quantification, and pattern recognition in natural product research [8].

Innovations in capillary liquid chromatography (Cap-LC) and its bioanalysis applications are explored. This review details advancements in column technology, detection methods, and microfluidic integration. It highlights Cap-LC's advantages in sensitivity, sample throughput, and minimal sample consumption for complex biological matrices, making it a key analytical tool [9].

Two-dimensional liquid chromatography (2D-LC) shows significant recent progress for highly complex samples. This paper focuses on advancements in instrumentation, column combinations, and method optimization. It demonstrates how 2D-LC offers superior peak capacity and resolution, making it indispensable for challenging separations across various scientific fields [10].

Description

The evolution of stationary phases is crucial for high-performance liquid chromatography. Research focuses on developing new materials and optimizing existing ones to enhance separation characteristics. This includes particle size, surface chemistries, and particle structures for efficiency and selectivity. These efforts are critical for resolving complex mixtures, broadening HPLC's applicability to challenging analytical problems [1]. High-performance liquid chromatography is indispensable for pharmaceutical analysis, serving multiple critical functions. It is employed for developing robust methods to separate and quantify active ingredients and related substances. Rigorous validation ensures regulatory compliance. HPLC is vital in drug discovery, quality control, and impurity profiling, collectively underpinning drug safety and efficacy [2]. Miniaturized HPLC systems, like micro- and nano-HPLC, represent a significant advancement. They offer advantages for limited sample availability or high sensitivity needs. In clinical diagnostics, they analyze minute biological samples. In pharmaceutical research, they facilitate high-throughput screening. Benefits include reduced solvent consumption, enhanced detection sensitivity, and accelerated analysis, making them promising for complex samples [3]. HPLC coupled with mass spectrometry (MS) has transformed natural product analysis. This powerful technique enables separation, identification, and quantification of complex botanical extracts. Innovations in interface design and ionization methods expand detectable molecules. Sophisticated data processing algorithms enhance interpretation of datasets, allowing precise characterization of natural product mixtures, aiding drug discovery [4]. Chiral stationary phases (CSPs) are pivotal for enantioselective separations in HPLC, vital for pharmacology. Distinguishing enantiomers is critical due to differential biological activities. Recent efforts focus on synthesizing new chiral selectors and modifying CSPs for improved resolution and efficiency. This research directly supports single-enantiomer drug development, enhancing drug safety and effectiveness [5]. Environmental sustainability drives innovations in green HPLC methodologies for pharmaceutical analysis. Advancements minimize ecological footprint without compromising performance. Strategies include reducing organic solvent volume, using eco-friendlier alternatives, and exploring alternative separation modes. The goal is sustainable chromatographic practices aligning with green chemistry, ensuring environmental protection and high drug analysis standards [6]. Ultra-high performance liquid chromatography (UHPLC) is a cornerstone in metabolomics, offering superior capabilities for comprehensive metabolite profiling. Its exceptional resolving power separates many similar compounds in biological matrices, providing detailed metabolic snapshots. Increased speed facilitates high-throughput analysis. Coupled with advanced mass spectrometry, UHPLC expands metabolite identification, yielding deeper insights into biological pathways and disease mechanisms [7]. The application of chemometric methods with HPLC-DAD and HPLC-MS platforms significantly advances phytochemical analysis. Chemometrics uses mathematical and statistical techniques to extract maximum information from complex chromatographic data. This approach is effective for intricate natural product mixtures, enhancing compound identification, improving quantification, and facilitating pattern recognition for sample classification. Such integration provides robust analytical solutions [8]. Capillary liquid chromatography (Cap-LC) continues to evolve as an indispensable tool in bioanalysis, offering unique advantages. It suits biological samples with limited volume or requiring high sensitivity. Advancements include improved column fabrication for robust, efficient columns, and highly sensitive detection methods. Microfluidic technologies enable automated sample preparation. These innovations make Cap-LC effective for profiling complex biological matrices with minimal consumption [9]. Two-dimensional liquid chromatography (2D-LC) offers a powerful solution for exceedingly complex samples, overcoming one-dimensional limitations. By combining two distinct, orthogonal separation mechanisms, 2D-LC dramatically increases peak capacity and resolution for intricate mixture characterization. Recent progress refines instrumentation, develops novel column combinations, and optimizes method parameters. This technique is indispensable for challenging separations across various fields [10].

Conclusion

Recent advancements across high-performance liquid chromatography (HPLC) and its related techniques are profoundly enhancing analytical capabilities in diverse scientific domains. Innovations include the development of advanced stationary phases, such as sub-2 µm particles and core-shell structures, significantly improving separation efficiency and selectivity. The pharmaceutical sector greatly benefits from these advancements, utilizing HPLC for critical applications like method validation, drug discovery, quality control, and impurity profiling. Miniaturized HPLC systems, including micro- and nano-HPLC, offer advantages in clinical diagnostics and pharmaceutical research through reduced sample consumption and enhanced sensitivity. Furthermore, the integration of HPLC with mass spectrometry (MS) has revolutionized natural product analysis by enabling precise identification and quantification of complex mixtures. Specialized chiral stationary phases are advancing enantioselective separations, which are vital for pharmaceutical development. Efforts in green HPLC methodologies are also reducing environmental impact without compromising analytical performance. Ultra-high performance liquid chromatography (UHPLC) is transforming metabolomics with superior resolution and speed, while chemometric methods are improving data interpretation for complex phytochemical analysis. Finally, capillary liquid chromatography (Cap-LC) and two-dimensional liquid chromatography (2D-LC) are pushing boundaries in bioanalysis and complex sample characterization, offering unprecedented sensitivity and peak capacity for challenging separations.

References

1. Qian Y, Zhong L, Hongmei Z. (2023) .TrAC Trends Anal Chem 161:117021.

   , ,

2. Shilpi S, Manoj S, Ritu D. (2022) .J Pharm Anal 12:843-855.

   , ,

3. Qing F, Zhihua Y, Hanqing L. (2021) .J Chromatogr A 1649:468249.

   , ,

4. Lei Z, Guangming S, Jianhua Z. (2023) .J Pharm Biomed Anal 224:115160.

   , ,

5. Hongying M, Danjuan L, Xinxin M. (2020) .J Chromatogr A 1629:461499.

   , ,

6. Yifei C, Fen T, Shuang Z. (2021) .J Pharm Biomed Anal 193:113709.

   , ,

7. Xi L, Yi L, Hua S. (2020) .TrAC Trends Anal Chem 133:116091.

   , ,

8. Coral B, María H, Ana M. (2021) .Curr Opin Biotechnol 71:12-19.

   , ,

9. Hui Y, Fei D, Chunfeng W. (2022) .Anal Chim Acta 1221:340118.

   , ,

10. Xiaoli L, Wenyi C, Qingying H. (2023) .TrAC Trends Anal Chem 162:117075.

    , ,